Cart
sales@molnova.com
Compound 1T-0216
CAS No. 383147-88-4
Compound 1T-0216( —— )
Catalog No. M28752 CAS No. 383147-88-4
Compound 1T-0216 is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 134 | In Stock |
|
| 10MG | 199 | In Stock |
|
| 25MG | 316 | In Stock |
|
| 50MG | 442 | In Stock |
|
| 100MG | 593 | In Stock |
|
| 200MG | 793 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCompound 1T-0216
-
NoteResearch use only, not for human use.
-
Brief DescriptionCompound 1T-0216 is a chemical compound.
-
DescriptionCompound 1T-0216 is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDHODH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number383147-88-4
-
Formula Weight397.387
-
Molecular FormulaC20H19N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1ccccc1C(=O)O\N=C1/CCCCC1c1ccc(cc1[N+]([O-])=O)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lucas-Hourani M, et al.Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH).J Med Chem. 2015 Jul 23;58(14):5579-98.
molnova catalog
related products
-
α-Synuclein (71-82) ...
α-Synuclein (71-82) (human) is the 71-82 fragment of α-Synuclein. α-Synuclein is an abundant neuronal protein that is highly abundant in presynaptic nerve terminals. α-Synuclein is a biomarker for Parkinson's disease (PD).
-
Berberine sulfate
Berberine sulfate (Berberal) is a quaternary ammonium salt of the benzylisoquinoline alkaloid proto-berberines, which can be used in the study of type 2 diabetes mellitus, abdominal obesity and metabolism-related fatty liver disease.
-
Picropodophyllin
Picropodophyllin (PPP) is a specific IGF-1R inhibitor (IC50: 1 nM). Picropodophyllin specifically inhibits the activity and downregulates the cellular expression of IGF1R without interfering with activities of other growth factor receptors.
